Beyond Antibodies

IBC’s third annual Beyond Antibodies conference is the industry’s only event to focus exclusively on alternatives to antibody technology. Next generation antibody and protein scaffolds are continually being developed and rapid advancements have been made in this highly emerging field. The development of these technologies is to overcome the limitations of traditional antibody technology and reduce the time of drug discovery. This year’s conference will cover the recent advancements and scientific benefits, as well as business perspectives driving much of the M & A activity.